GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 78 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $273,000 | -7.1% | 28,322 | +14.0% | 0.00% | 0.0% |
| Q2 2017 | $294,000 | -11.4% | 24,839 | -4.2% | 0.00% | 0.0% |
| Q1 2017 | $332,000 | +8.9% | 25,936 | +3.9% | 0.00% | 0.0% |
| Q4 2016 | $305,000 | -1.0% | 24,955 | -4.4% | 0.00% | 0.0% |
| Q3 2016 | $308,000 | +35.7% | 26,112 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $227,000 | +56.6% | 26,112 | -5.4% | 0.00% | 0.0% |
| Q1 2016 | $145,000 | -32.2% | 27,604 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $214,000 | +0.5% | 27,604 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $213,000 | -13.1% | 27,069 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $245,000 | -38.3% | 27,069 | -11.4% | 0.00% | -50.0% |
| Q1 2015 | $397,000 | -8.3% | 30,556 | -3.9% | 0.00% | 0.0% |
| Q4 2014 | $433,000 | +50.9% | 31,783 | -0.6% | 0.00% | +100.0% |
| Q3 2014 | $287,000 | -33.1% | 31,969 | +0.8% | 0.00% | -50.0% |
| Q2 2014 | $429,000 | +56.0% | 31,710 | +14.7% | 0.00% | +100.0% |
| Q1 2014 | $275,000 | -25.3% | 27,648 | 0.0% | 0.00% | -50.0% |
| Q4 2013 | $368,000 | +6.1% | 27,648 | -3.2% | 0.00% | 0.0% |
| Q3 2013 | $347,000 | +261.5% | 28,563 | +206.9% | 0.00% | +100.0% |
| Q2 2013 | $96,000 | – | 9,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|